Birdwatch Note Rating
2024-11-29 03:58:31 UTC - HELPFUL
Rated by Participant: 8FF3883314DD303E097EDDDBD7C318379D0659CDF623AD64D90144129441E807
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details